Direct Cost of Cardiovascular Diseases in Cardiology Department of University Hospital Gabriel Touré (Uh Gt): Comparative Study Between Patients With and Without Medical Insurance

Résumé fourni par la source

Aim: This study aims to compare cardiovascular diseases direct costs for patients with and those without medical insurance.Methods: It was a prospective study from Mai 02 to August 31 2016 in the cardiology department of the UH GT.All outpatients aged 15 years and older, who came to visit, accepted to participate in the study and were involved.Direct costs (transport, consultation, labor tests and medicaments) were recorded for each patient at each visit.Data were inserted in a MS Access 2010 database and exported in SPSS 20 for analysis, comparing 2 groups (patients with and without medical insurance).Chi-2 and Fisher tests if applicable were used for statistical tests.Results: All patients seen in the study time (922 patients of whom 62.9% were female and 35.7% between 60-74 years ) were included.A proportion of 30.5% had medical insurance (281/922).Patients with diabetes, dyslipidemia and obesity were found among patients with medical insurance with respectively 47.5, 62.4 and 49.2%.Most frequent cardiovascular diseases among patients with medical insurance were high blood pressure without and with complications, acute coronary syndrome with respectively 36.2, 34.7 and 29.2%.Direct costs for patients with medical insurance were 1.06 to 1.77 times higher.Labor tests generated the highest costs.Direct costs for all cardiovascular diseases were higher for patients without medical insurance, up to 4 times for venous thrombo-embolic disease.Total costs were higher for patients with medical insurance.Conclusions: Direct costs for pathologies were higher for patients without medical insurance.Palpitation was the only pathology with direct costs higher for patients with medical insurance.Total costs for patients were higher for patients with medical insurance.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.